This is a snippet of the transcript, sign up to read more.
Other industries have been practicing direct purchasing and private labeling for years, but healthcare is only just catching up. Tecsys has provided healthcare systems with the opportunity to self-distribute, essentially cutting out the middlemen, known as global purchasing organizations or distributors, such as McKesson, Owens & Minor, and Cardinal.
This is a snippet of the transcript, sign up to read more.
While Tecsys may be seen as a threat by these organizations, they are evolving to become more flexible and useful to health systems. However, many health systems still rely solely on distributors like Owens & Minor, which is not an efficient way to manage a supply chain, as the pandemic has clearly shown. The shift in healthcare has been towards direct sourcing from suppliers, having alternative sources, and ensuring substitutions for essential items in primary care.
This is a snippet of the transcript, sign up to read more.
Most sizable organizations lean towards a hybrid model where they've outsourced their warehouse operations but are no longer single-sourced. For instance, Owens & Minor might manage a warehouse, but they're handling products that you've purchased directly, or from GPOs, or even from other health systems with a better supply chain.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research